Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
No Data
Wall Street Analysts Are Bullish on Top Healthcare Picks
Kapoor Reiterates Buy on Oruka Therapeutics as Pipeline Advances; Keeps $120 Price Target Unchanged
UBS Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $100
Piper Sandler Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $180
Piper Sandler Sticks to Their Buy Rating for Oruka Therapeutics (ORKA)
UBS Sticks to Its Buy Rating for Oruka Therapeutics (ORKA)